Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction
Geoffrey de Couto, … , Moshe Arditi, Eduardo Marbán
Geoffrey de Couto, … , Moshe Arditi, Eduardo Marbán
Published July 27, 2015
Citation Information: J Clin Invest. 2015;125(8):3147-3162. https://doi.org/10.1172/JCI81321.
View: Text | PDF
Research Article Cardiology

Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction

  • Text
  • PDF
Abstract

Ischemic injury in the heart induces an inflammatory cascade that both repairs damage and exacerbates scar tissue formation. Cardiosphere-derived cells (CDCs) are a stem-like population that is derived ex vivo from cardiac biopsies; they confer both cardioprotection and regeneration in acute myocardial infarction (MI). While the regenerative effects of CDCs in chronic settings have been studied extensively, little is known about how CDCs confer the cardioprotective process known as cellular postconditioning. Here, we used an in vivo rat model of ischemia/reperfusion (IR) injury–induced MI and in vitro coculture assays to investigate how CDCs protect stressed cardiomyocytes. Compared with control animals, animals that received CDCs 20 minutes after IR had reduced infarct size when measured at 48 hours. CDCs modified the myocardial leukocyte population after ischemic injury. Specifically, introduction of CDCs reduced the number of CD68+ macrophages, and these CDCs secreted factors that polarized macrophages toward a distinctive cardioprotective phenotype that was not M1 or M2. Systemic depletion of macrophages with clodronate abolished CDC-mediated cardioprotection. Using both in vitro coculture assays and a rat model of adoptive transfer after IR, we determined that CDC-conditioned macrophages attenuated cardiomyocyte apoptosis and reduced infarct size, thereby recapitulating the beneficial effects of CDC therapy. Together, our data indicate that CDCs limit acute injury by polarizing an effector macrophage population within the heart.

Authors

Geoffrey de Couto, Weixin Liu, Eleni Tseliou, Baiming Sun, Nupur Makkar, Hideaki Kanazawa, Moshe Arditi, Eduardo Marbán

×

Figure 4

CDC-treated animals have a reduced CD68+ macrophage population 48 hours after IR.

Options: View larger image (or click on image) Download as PowerPoint
CDC-treated animals have a reduced CD68+ macrophage population 48 hours ...
(A) Gating strategy for leukocyte identification within the infarcted myocardium prior to subset analysis. CD45+ cells were first identified (FSC-A/CD45+), and then dead cells were excluded (DAPI–). (B) Pooled flow cytometry data from infarcted rat tissue reveal a reduced CD68+ population in CDC- vs. PBS-treated hearts (n = 4 rats per group). (C) Immunohistochemical staining of hearts within the infarct zone from CDC- and PBS-treated animals at 2, 6, and 48 hours after IR (n = 4 rats per group). Scale bar: 50 μm. (D) Pooled data from CD68+ cells within the infarct tissue from C at 2, 6, and 48 hours after IR (n = 4 rats per group). (E) Concentration of cytokines MCP-1 (CCL2) and IL-4 in sera 48 hours after IR (n = 4–8 rats per group). Graphs depict mean ± SEM. Statistical significance was determined using Student’s t test and 2-way ANOVA followed by Bonferroni’s multiple comparisons test. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts